Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathwayXingchen Li, Jinpu Yu|Clinical and Translational Medicine|2023Cited by 24
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutationsWenxian Wang, Fan Xia, Nan Zheng et al.|The Innovation|2024Cited by 12